Cancer Radiation Therapy Market – Oncology’s Precision Frontier

Jun 26, 2025 - 18:12
 1

The Cancer Radiation Therapy Market is witnessing a paradigm shift due to technological innovations, rising global cancer cases, and the demand for personalized treatment options. With over 60% of cancer patients receiving some form of radiotherapy, this modality is vital in the multi-pronged fight against cancer.

Radiation Types

  • External Beam Radiation Therapy (EBRT) – Includes 3D-CRT, IMRT, IGRT

  • Proton Therapy – Precision-focused, ideal for pediatric and brain cancers

  • Stereotactic Body Radiotherapy (SBRT) – Few high-dose sessions

  • Brachytherapy – Internal radiation for localized tumors

Technology Highlights

  • AI Integration: Helps in personalized planning and error detection

  • Image-Guided Radiation Therapy (IGRT): Enhances precision during sessions

  • Adaptive Radiotherapy: Real-time adjustment based on tumor movement

Global Reach

  • North America: High uptake due to tech readiness

  • Asia Pacific: Rapid infrastructure growth, cancer burden, and medical tourism

  • Europe: Public health models expanding access to precision care

Leading Companies

  • Varian Medical Systems

  • Elekta AB

  • Siemens Healthineers

  • Accuray Inc.

  • ViewRay Inc.

Challenges & Opportunities

  • High cost of installation

  • Infrastructure gaps in low-income countries

  • Demand for outpatient, AI-guided radiation suites

2031 Vision

The future of radiation therapy lies in automation, precision, and universal accessibility. With the advent of AI, real-time planning, and proton beam access in community hospitals, cancer treatment will become faster, safer, and more individualized.

🔗 Access Full Report